JAK inhibitors are one of the many new types of treatments for people with eczema. This new drug fights symptoms at the cellular level and can be administered orally or topically. Clinical trial data shows that JAK inhibitors provide study participants with a number of benefits including: *Achievement of “clear” or “almost clear” skin *Improved eczema area and severity index scores lessening of redness, thickness, scratching, skin markings and scaling https://nationaleczema.org/blog/jak-inhibito

The Basics: Eczema

Eczema & COVID-19: Treatment considerations